Back to Top Skip to main content Skip to sub-navigation

Behind the scenes, DHA supports DOJ to fight compound drug fraud

Image of several large prescription bottles filled with pills The medicine in large pills can be mixed into a solution by the pharmacist and given orally. This action is commonly called “compound drugs;” such medications mix or alter a recipe of ingredients to meet a patient’s needs. However, compound drugs are not FDA-approved. (Photo by Senior Airman Hailey Staker, 28th Bomb Wing.)

Recommended Content:

TRICARE Health Program | TRICARE Pharmacy Program | Compound Drugs | Health Literacy Month 2020

If a child needs medicine in a pill that is too large to swallow, that medication can be mixed into a solution by the pharmacist and given to the child orally. This action is commonly called “compound drugs;” such medications mix or alter a recipe of ingredients to meet a patient’s needs. While patients can be treated with compound drugs without the complications from their commercially sold counterparts, the drugs create a new potential complication: medical fraud from nefarious pharmacies and providers.

Bryan Wheeler, chief of Program and Health Law and former acting general counsel at the Defense Health Agency, has followed and fought compound drug fraud committed through the TRICARE health benefit since 2015.

“We recognized that we [TRICARE] were spending an inordinate amount of money on compound drugs,” Wheeler said, “so we had to follow the money to see where the problem was coming from.”

Compound drugs are not FDA-approved, but because DHA has an open formulary, TRICARE covers and reimburses providers for certain drug ingredients. This reimbursement helped providers looking for a cost-efficient way to cater to their patients’ needs, but without even meeting a patient, individuals looking for easy money wrote false prescriptions to get reimbursed for expensive ingredients.

“In these scams, the folks providing the ingredients make money off this, pharmacists make money off this, even the doctor that writes the prescription makes money off this,” Wheeler said. “What we saw were these networks of people recruiting patients, physicians, and pharmacies to request fake prescriptions under false pretenses. These individuals would the request prescriptions for patients who had not requested them, or request prescriptions that were not medically necessary."

DHA coordinated with the Department of Justice and the Department of Defense’s Criminal Investigative Service in prosecuting individuals and companies who have committed compound drug fraud through TRICARE. So far, the government has improved care for its beneficiaries by recovering over $606 million to TRICARE in court-ordered restitution, civil judgments, and determination of improper payments. Some offenders are currently serving jail time; program exclusion for pharmacies and individuals can range up to 20 years. DHA’s Program Integrity Division and Pharmacy Operations Division work together to observe trends and create policies to prevent future fraud.

“We have numerous controls and indicators that we look at not just for compound pharmaceuticals, but in general, that help to shed some light on areas we may want to look at more closely,” said Jennifer Dietz, head of the Program Integrity Division.

Examples include the implementation of a compound exclusion list. If a provider or pharmacy files a claim through TRICARE to be reimbursed for an ingredient that shows up on the exclusion list, the claim is paused. The provider then must verify its relationship with the patient and justify the choice of ingredients in the prescription. Only then will the reimbursement be processed.

DHA’s Program Integrity Division also compiles “spike reports” to observe trends in claims within peer groups of providers and pharmacies. DHA uses link analysis to look for spikes in ingredients or claims filed within these peer groups. Compiled data can identify other potential fraud cases, add ingredients to the compound exclusion list, and help DHA identify providers or pharmacies that show up frequently in areas that are known for compound drug fraud.

Since these new implementations, DHA has seen a severe drop in new fraudulent compound drug claims. However, since no statute of limitations exists for recovering money from compound drug fraud, the team learns about old cases regularly. These cases are forwarded to agencies like DOJ and the Defense Criminal Investigative Service for actions that include pursuing restitution fees.

“I can say without a doubt that DHA is committed to protecting not only taxpayer funds, but safeguarding benefit dollars for our military,” Dietz said. “And we’ll continue working to keep that promise.”

You also may be interested in...

Download Letter to Beneficiaries

Publication
6/24/2020

This message replaces guidance issued on March 31. It explains actions military pharmacies are taking to keep services and visits safe during the COVID-19 pandemic, and it outlines your pharmacy options as a TRICARE beneficiary.

Recommended Content:

Coronavirus | COVID Pharmacy Guidance | TRICARE Health Program

Communication to ABA Providers Regarding Continued Temporary Authorization to Utilize Telehealth for CPT Code 97156 During the COVID-19 National Emergency

Publication
6/3/2020

TRICARE is announcing the continuation of the temporary exception to policy regarding the use of synchronous telehealth (TH) capabilities (both audio and video) for Applied Behavior Analysis (ABA) Family Adaptive Behavior Treatment Guidance services specifically during this COVID-19 pandemic.

Recommended Content:

Coronavirus | TRICARE Health Program

Benefits Eligibility for 32 USC 502(f) Missions

Publication
4/14/2020

A chart outlining the various Benefits Eligibility for 32 USC 502(f) Missions

Recommended Content:

Coronavirus | TRICARE Health Program

Decision Memorandum on TRICARE Implementation of the "Families First Coronavirus Response Act"

Publication
4/7/2020

The Families First Coronavirus Response Act, Public Law 116-127, Division F, Section 6006(a), limits TRICARE authority to impose copayment or other cost-sharing for novel coronavirus (COVID-19) testing and related provider visits that result in orders for or administration of Food and Drug Administration (FDA) approved, cleared, or authorized diagnostic products. In order for the Defense Health Agency (DHA) to implement, the Assistant Secretary of Defense for Health Affairs (ASD(HA)) must acknowledge the self-executing authority of the statute and direct the Director, DHA, or designee, to issue guidance implementing the statutory provisions.

Recommended Content:

TRICARE Health Program | Coronavirus

Pharmacy Guidance for Market MTFs

Publication
3/31/2020

Message to Pharmacy Beneficiaries regarding military pharmacy services during the COVID-19 pandemic.

Recommended Content:

Coronavirus | Pharmacy Division | TRICARE Health Program

Tiered Telehealth Health Care Support for COVID-19

Publication
3/31/2020

This memorandum establishes guidance for the use of Telehealth (TH) Information Technology (IT) tools in support of the clinical care required for patients across the spectrum of COVID-19 illness

Recommended Content:

TRICARE Health Program | Public Health | Coronavirus

Policy Exception for Telehealth Use for ABA during COVID-19 Pandemic

Publication
3/30/2020

Communication to ABA Providers Regarding Temporary Authorization to Utilize Telehealth for CPT Code 97156 During the COVID-19 National Emergency

Recommended Content:

Coronavirus | TRICARE Health Program

Q & A: Policy Exception for Telehealth Use for ABA during COVID-19 Pandemic

Publication
3/30/2020

Question and Answer: TRICARE Autism Care Demonstration (ACD): Regarding Temporary Authorization to Utilize Telehealth for CPT Code 97156 during the COVID-19 National Emergency

Recommended Content:

Coronavirus | TRICARE Health Program

3D Mammography Toolkit

Publication
12/19/2019

Recommended Content:

TRICARE Health Program | Women's Health

3D Mammography Infographic 1

Publication
12/16/2019

Share this infographic to spread the word about 3-D Mammography coverage

Recommended Content:

TRICARE Health Program | Women's Health

3D Mammography Infographic 2

Publication
12/16/2019

Share this infographic to spread the word about 3-D Mammography coverage

Recommended Content:

TRICARE Health Program | Women's Health

Talking_Points_3D_Mammography

Publication
12/16/2019

These talking points share information about 3-D mammography

Recommended Content:

TRICARE Health Program | Women's Health

Open Season and BWE Issue Annex

Publication
11/23/2019

This Open Season and BWE Issue Annex contains products with additional information about how to enroll during Open Season

Recommended Content:

TRICARE Health Program

Annex TRICARE Open Season 2019 Infographic 11x17 Flattened

Publication
11/22/2019

Share this to spread information about Open Season enrollment!

Recommended Content:

TRICARE Health Program

BWE Issues How to Enroll During Open Season

Publication
11/22/2019

Share this to spread information about BWE experiencing a technical issue

Recommended Content:

TRICARE Health Program
<< < 1 2 3 > >> 
Showing results 1 - 15 Page 1 of 3

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.